Hanmi Pharm. Co., Ltd. Investor Relations Event
HAI summary · Not investment advice
Hanmi Pharmaceutical will hold one-on-one in-person meetings for domestic institutional investors on November 2 as part of a Mirae Asset Securities NDR.
Key facts
- IR date and time
- Nov 2, 2026Starts at 10:00
- Venue
- Seoul
- Audience
- Domestic institutional investors
- Purpose
- Participation in Mirae Asset Securities NDR (Non-Deal Roadshow)
- Format
- One-on-one in-person meetings
- Main topics
- Explanation of key Q3 2026 business results, Q&A
- Sponsor
- Mirae Asset Securities
- Materials posting date
- Oct 30, 2026
- Materials location
- Company website (IR-IR Library)
Commentary
AI commentary · Not investment advice
What happened
Hanmi Pharmaceutical will hold an IR event in Seoul on November 2, 2026, at 10:00. It takes part in a Non-Deal Roadshow (NDR) sponsored by Mirae Asset Securities, and the sessions are one-on-one in-person meetings with domestic institutional investors. The agenda covers an explanation of key business results for the third quarter of 2026, followed by a Q&A.
In the company's terms
The filing gives no ratios and no comparison with past IR events. It covers only the schedule, audience, format and topics of the meetings.
What changes for shareholders
The presentation materials were posted on October 30, 2026 on the company website, in the IR materials section. Shareholders can check the same materials there.
Earlier Investor Relations Event filings from this company
| Filed | Title | Key figure · Note |
|---|---|---|
| 26.11.022026.11.02 | Investor Relations Event | — |
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist